Skip to main content
    D

    DocGo Inc (DCGO)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.19
    -0.02 (-8.53%)

    Market Cap: $20.55M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    DocGo Inc (DCGO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    DocGo reported revenue of $322.20M for the fiscal year ended Dec 31, 2025, down 47.7% from the year before. That year, net income was -$196.37M with a net margin of -60.9%, operating cash flow was $34.45M and free cash flow was $29.91M. The quarter ended Sep 30, 2026 had revenue of $73.43M and net income of -$18.29M.

    Revenue and Margins

    The operating margin was -55.3% in the fiscal year ended Dec 2025, the lowest of the 7 years shown. Over the 6 years to Dec 2025, revenue grew from $48.30M, a compound annual rate of 37.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$322.20M-47.7%30.7%-55.3%-60.9%
    Dec 2024$616.56M-1.2%34.6%4.7%2.2%
    Dec 2023$624.29M+41.7%31.3%2.4%1.6%
    Dec 2022$440.52M+38.2%35.1%5.0%7.0%
    Dec 2021$318.72M+238.7%34.4%4.8%6.0%
    Dec 2020$94.09M+94.8%33.3%-15.7%-15.7%
    Dec 2019$48.30MN/A27.3%-43.0%-41.8%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$322.20M$616.56M$624.29M$440.52M$318.72M$94.09M$48.30M
    Cost of revenue$223.44M$402.98M$428.91M$285.79M$208.97M$62.74M$35.11M
    Gross profit$98.76M$213.57M$195.38M$154.72M$109.75M$31.35M$13.19M
    Research and development$13.56M$11.59M$10.86M$5.38M$3.32M$1.19M$1.22M
    Operating income-$178.03M$28.69M$15.05M$21.83M$15.36M-$14.76M-$20.76M
    Net income-$196.37M$13.36M$10.05M$30.74M$19.18M-$14.80M-$20.21M
    EBITDA-$170.35M$45.88M$31.38M$32.58M$27.55M-$8.92M-$16.58M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$73.43M$73.42M$75.55M$74.94M$70.81M$80.42M$96.03M$120.83M$138.68M$164.95M$192.09M$199.25M
    Gross profit$73.43M$73.42M$75.55M-$148.50M$70.81M$80.42M$96.03M-$282.15M$138.68M$164.95M$192.09M-$98.16M
    Operating income-$17.28M-$17.92M-$18.71M-$104.58M-$41.98M-$17.48M-$14.00M-$7.47M$10.14M$10.15M$15.88M$11.67M
    Net income-$18.29M-$17.99M-$16.70M-$142.34M-$29.66M-$13.29M-$11.08M-$7.65M$4.55M$5.86M$10.60M$7.99M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $3.28M by $47.74M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$217.10M$455.62M$490.45M$393.28M$309.60M$100.17M$100.96M
    Current assets$152.40M$304.49M$338.87M$271.08M$256.03M$58.42M$59.14M
    Cash and equivalents$51.02M$89.24M$59.29M$157.34M$175.54M$32.42M$47.74M
    Total liabilities$91.23M$140.44M$185.28M$114.35M$82.55M$33.23M$21.60M
    Short-term debt$3.09M$34.99M$25.03M$664.91K$626.33K$664.36K$3.67M
    Long-term debt$183.84K$5.21K$41.59K$1.24M$1.30M$594.49K$751.50K
    Shareholder equity$144.01M$320.92M$300.79M$273.23M$219.58M$55.00M$68.47M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$173.90M$186.82M$209.23M$217.10M$353.78M$408.26M$430.79M$455.62M$493.88M$488.17M$490.69M$490.45M
    Total liabilities$94.92M$91.04M$98.02M$91.23M$93.12M$120.53M$128.87M$140.44M$168.98M$170.18M$175.61M$185.28M
    Cash and equivalents$19.11M$25.23M$35.68M$51.02M$73.36M$104.16M$79.01M$89.24M$89.46M$66.06M$41.24M$59.29M
    Shareholder equity$105.08M$119.05M$132.31M$144.01M$270.53M$297.28M$309.34M$320.92M$325.21M$315.16M$311.32M$305.17M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 86.8% of operating cash flow. Dividends and share repurchases together came to 36.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$34.45M$70.12M-$64.49M$28.87M-$1.95M-$10.65M-$14.21M
    Capital expenditures$4.54M$3.61M$7.31M$3.20M$4.81M$4.36M$3.80M
    Free cash flow$29.91M$66.50M-$71.81M$25.67M-$6.76M-$15.02M-$18.01M
    Dividends paid$175.83K$3.14M$0$0$19.96MN/AN/A
    Share repurchases$10.83M$13.76M$0$3.75M$0$0N/A
    Investing cash flow-$39.08M-$10.65M-$29.61M-$38.45M-$8.59M-$6.04M-$2.97M
    Financing cash flow-$50.82M-$24.15M$1.12M-$6.18M$155.21M-$812.09K$56.34M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$3.62M-$9.24M-$4.66M-$10.47M$1.66M$34.04M$9.22M$12.72M$31.15M$36.89M-$10.64M-$6.19M
    Capital expenditures$2.16M$320.83K$430.31K$1.50M$2.95M$1.14M$1.03M$724.80K$902.16K$1.03M$951.70K$2.95M
    Free cash flow-$5.78M-$9.56M-$5.09M-$11.96M-$1.29M$32.90M$8.19M$11.99M$30.25M$35.85M-$11.59M-$9.14M
    Last 12 quarters

    Frequently Asked Questions About DCGO

    What is DocGo's annual revenue?

    DocGo reported revenue of $322.20M for the fiscal year ended Dec 31, 2025.

    How fast is DocGo's revenue growing?

    Revenue was down 47.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -9.9%.

    Is DocGo profitable?

    No. DocGo reported net income of -$196.37M for the fiscal year ended Dec 31, 2025, with a net margin of -60.9%.

    How much free cash flow does DCGO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $34.45M minus capital expenditures of $4.54M produced free cash flow of $29.91M.

    How much debt does DocGo have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $183.84K, short-term debt of $3.09M and cash and equivalents of $51.02M.